Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06348186

Fascial Tissue Response to Manual Therapy: Implications in Long COVID-19

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of the State of Santa Catarina · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

According to the World Health Organization (WHO), as of mid-September 2022, more than 21 million Brazilians have recovered from COVID-19. However, post-infection symptoms continue to appear months after the end of the acute infection, a syndrome called long COVID. Therefore, the aim of this study is to investigate the responses of fascia-focused manual therapy in participants with long COVID.

Detailed description

Participants reported to have long COVID, of both sexes, aged between 20 and 80 years, from the community, outpatient clinics and hospitals will be evaluated. The treatment of participants will be carried out at the CEFID-UDESC Physiotherapy School Clinic, where they will undergo assessment of the biomechanical and viscoelastic properties of tissues, postural control, pain and quality of life. For normality analysis, the Shapiro-Wilk test will be applied, and according to the distribution of the data, parametric or non-parametric tests will be used. Pre- and post-assessment and treatment data will be compared using descriptive statistics and Student's t-test with a significance level of p=0.05 for parametric data or Wilcoxon for non-parametric data.

Conditions

Interventions

TypeNameDescription
OTHERGuidebookFolder that will be given to the participant to carry out 5 minutes of intervention daily
OTHERGuidebook and Myofascial Reorganization® (RMF).The intervention will be carried out once a week for 30 minutes for 6 weeks. It will include passive, active-assisted moments (with and without load). In addition to a folder that will be given to the participant to carry out 5 minutes of intervention daily.

Timeline

Start date
2024-02-01
Primary completion
2024-04-01
Completion
2025-08-31
First posted
2024-04-04
Last updated
2024-11-20

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT06348186. Inclusion in this directory is not an endorsement.